Evidence map›Paper›PMID 31996255›Full record

ArticleParticle and fibre toxicology2020

LiCoO

Violaine Sironval, Vittoria Scagliarini, Sivakumar Murugadoss, Maura Tomatis, Yousof Yakoub, Francesco Turci, Peter Hoet, Dominique Lison, Sybille van den Brule

Open access · goldAbstract read
In one paragraph

Article in Particle and fibre toxicology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Naphthalene Monoimides withMaterials (Basel, Switzerland) · 2023
    Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Violaine SironvalLouvain centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Avenue Hippocrate 57, box B1.57.06, 1200, Brussels, Belgium. violaine.sironval@uclouvain.be.ORCID 0000-0003-4914-9044
Vittoria ScagliariniLouvain centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Avenue Hippocrate 57, box B1.57.06, 1200, Brussels, Belgium.
Sivakumar MurugadossLaboratory of Toxicology, Unit of Environment and Health, Department of Public Health and Primary Care, Katholieke Universiteit Leuven, Herestraat 49 - O&N1 - Room: 07.702, box 706, 3000, Leuven, Belgium.
Maura TomatisDepartment of Chemistry and "G. Scansetti" Interdepartmental Center for Studies on Asbestos and Other Toxic Particulates, University of Torino, Via P. Giuria 7, 10125, Torino, Italy.
Yousof YakoubLouvain centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Avenue Hippocrate 57, box B1.57.06, 1200, Brussels, Belgium.
Francesco TurciDepartment of Chemistry and "G. Scansetti" Interdepartmental Center for Studies on Asbestos and Other Toxic Particulates, University of Torino, Via P. Giuria 7, 10125, Torino, Italy.
Peter HoetLaboratory of Toxicology, Unit of Environment and Health, Department of Public Health and Primary Care, Katholieke Universiteit Leuven, Herestraat 49 - O&N1 - Room: 07.702, box 706, 3000, Leuven, Belgium.
Dominique LisonLouvain centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Avenue Hippocrate 57, box B1.57.06, 1200, Brussels, Belgium.
Sybille van den BruleLouvain centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Avenue Hippocrate 57, box B1.57.06, 1200, Brussels, Belgium.
UCLouvain · BEKU Leuven · BEUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLi-ion batteries (LIB) are used in most portable electronics. Among a wide variety of materials, LiCoO

resultsWe assessed the mutagenic potential of LCO and LTO particles in vitro by performing a cytokinesis-block micronucleus (MN) assay with rat lung epithelial cells (RLE), as well as in vivo in alveolar type II epithelial (AT-II) cells. LCO particles induced MN in vitro at non-cytotoxic concentrations and in vivo at non-inflammatory doses, indicating a primary genotoxic mechanism. LTO particles did not induce MN. Electron paramagnetic resonance and terephthalate assays showed that LCO particles produce hydroxyl radicals (•OH). Catalase inhibits this •OH production. In an alkaline comet assay with the oxidative DNA damage repair enzyme human 8-oxoguanine DNA glycosylase 1, LCO particles induced DNA strand breaks and oxidative lesions. The addition of catalase reduced the frequency of MN induced by LCO particles in vitro.

conclusionsWe report the mutagenic activity of LCO particles used in LIB in vitro and in vivo. Our data support the role of Co(II) ions released from these particles in their primary genotoxic activity which includes the formation of •OH by a Fenton-like reaction, oxidative DNA lesions and strand breaks, thus leading to chromosomal breaks and the formation of MN. Documenting the genotoxic potential of the other LIB particles, especially those containing Co and/or Ni, is therefore needed to guarantee a safe and sustainable development of LIB.

Indexed as

DNA DamageAlveolar Epithelial CellsAnimalsBronchoalveolar Lavage FluidCells, CulturedCell SurvivalCobaltElectric Power SuppliesFemaleHydroxyl RadicalLungMicronuclei, Chromosome-DefectiveOxidesParticle SizeParticulate MatterRatsCobaltHydroxyl Radicallithium cobalt oxideOxidesParticulate MatterComet assayGenotoxicityMicronucleus assay

Identifiers

PMID31996255
PMCPMC6990559
OpenAlexW3013859347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.